Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ultrathin Electrospun Poly(γ-benzyl‑l‑glutamate) Nanofibrous Membranes for Retinal Pigment Epithelial Cell Cultivation. | ACS Omega | 2026 | 42077854 | PubTator, text mining | PubMed |
| Gene-Agnostic Therapeutic Strategies for Inherited Retinal Diseases: Neuroprotection and Immunomodulation. | Genes (Basel) | 2026 | 42074510 | PubTator, text mining | PubMed |
| Structural, functional and patient-reported 24-month outcomes of voretigene neparvovec in Portuguese patients with RPE65-associated disease. | Eye (Lond) | 2026 | 41998128 | PubTator, text mining | PubMed |
| Real-World Comparison of Overall Survival Among Patients With and Without Inherited Retinal Diseases. | Vision (Basel) | 2026 | 41893425 | PubTator, text mining | PubMed |
| CRISPR and Beyond: Genome-Editing Strategies in Retinal Stem Cell Research. | Cells | 2026 | 41892280 | PubTator, text mining | PubMed |
| AAV2-Retro-Mediated Gene Transfer Selectively Targets Outer Retinal Cells Following Intravitreal Injection. | Invest Ophthalmol Vis Sci | 2026 | 41891763 | PubTator, text mining | PubMed |
| Expert Consensus on Characteristics, Etiology, and Management of Chorioretinal Atrophy in Patients Treated with Voretigene Neparvovec. | Ophthalmol Sci | 2026 | 41853567 | PubTator, text mining | PubMed |
[Results of the multicenter study "Registry of patients with inherited retinal dystrophies caused by confirmed biallelic mutations in the RPE65 and RLBP1 genes in Russia (REGINA)". Report 2. Clinical, social and demographic characteristics of inherited retinal pathologies]. | Vestn Oftalmol | 2026 | 41847811 | PubTator, text mining | PubMed |
[Results of the multicenter study "Registry of patients with inherited retinal dystrophies caused by confirmed biallelic mutations in the RPE65 and RLBP1 genes in Russia (REGINA)". Report 1. Molecular genetic characteristics of inherited retinal pathologies]. | Vestn Oftalmol | 2026 | 41847810 | PubTator, text mining | PubMed |
| A heterozygous pathogenic RPE65 variant phenocopies a mitochondrial retinopathy. | Ophthalmic Genet | 2026 | 41845931 | PubTator, text mining | PubMed |
| The evolution of lipid nanoparticles: Paving the way for next-generation nucleic acid medicines. | Asian J Pharm Sci | 2026 | 41810472 | PubTator, text mining | PubMed |
| Proteomic mapping of Rosa damascena nanovesicles reveals plastid mitochondrial metabolic convergence and antimicrobial peptides. | Plant Signal Behav | 2026 | 41803707 | PubTator, text mining | PubMed |
| Ciliary Defects in Inherited Retinal Diseases. | Adv Genet (Hoboken) | 2026 | 41798690 | PubTator, text mining | PubMed |
| A model of coagulation-related genes for prediction of prognosis in lung adenocarcinoma and verification in vitro. | Sci Prog | 2026 | 41793132 | PubTator, text mining | PubMed |
| Advanced therapeutic approaches for inherited retinal diseases: an umbrella review. | BMJ Open | 2026 | 41760155 | PubTator, text mining | PubMed |
| Prime Editing Driven Functional Genomics: Bridging Genotype to Phenotype in the Post-Genomic Era. | Int J Mol Sci | 2026 | 41751840 | PubTator, text mining | PubMed |
| Exploration and Application of Multiluminance Mobility Test in Bietti Crystalline Dystrophy. | Transl Vis Sci Technol | 2026 | 41746132 | PubTator, text mining | PubMed |
| Fucoidan from Fucus vesiculosus Protects Retinal Pigment Epithelium from Lipid-Induced Damage Related to AMD. | Mar Drugs | 2026 | 41745467 | PubTator, text mining | PubMed |
| Ferroptosis in diabetic retinopathy: from pathogenic mechanisms to translational prospects. | Front Endocrinol (Lausanne) | 2026 | 41710412 | PubTator, text mining | PubMed |
| MENDELSEEK: An algorithm that predicts mendelian genes and elucidates what makes them special. | PLoS Comput Biol | 2026 | 41701800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=2